tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Holding VYNE?
Track your performance easily

VYNE Therapeutics (VYNE) Income Statement

1,810 Followers

VYNE Therapeutics Income Statement

Last quarter (Q1 2024), VYNE Therapeutics's total revenue was $98.00K, a decrease of -1.01% from the same quarter last year. In Q1, VYNE Therapeutics's net income was $-6.25M. See VYNE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 423.00K$ 424.00K$ 477.00K$ 931.00K$ 20.99M$ 0.00
Cost of Revenue
---$ 3.35M$ 1.39M-
Gross Profit
$ 401.00K$ 400.00K$ 477.00K$ 931.00K$ 19.60M-
Operating Expense
$ 31.19M$ 29.68M$ 34.77M$ 39.84M$ 133.08M$ 76.24M
Operating Income
$ -30.76M$ -29.26M$ -34.30M$ -38.91M$ -113.47M$ -76.24M
Net Non Operating Interest Income Expense
---$ -5.61M$ -4.39M$ 2.54M
Other Income Expense
$ -2.26M$ -1.39M$ -363.00K$ 135.00K$ -137.96M-
Pretax Income
$ -28.50M$ -27.87M$ -33.93M$ -44.66M$ -255.83M$ -73.70M
Tax Provision
$ -123.00K$ -123.00K$ 13.00K$ -448.00K$ -258.00K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.06M$ -28.45M$ -33.95M$ -44.21M$ -255.57M$ -73.70M
Basic EPS
$ -1.19$ -2.78$ -7.28$ -25.64$ -7.88$ -12.36
Diluted EPS
$ -1.19$ -2.78$ -7.28$ -25.64$ -7.88$ -12.36
Basic Average Shares
$ 80.42M$ 10.27M$ 3.19M$ 2.86M$ 32.42M$ 5.95M
Diluted Average Shares
$ 80.42M$ 10.27M$ 3.19M$ 2.86M$ 32.42M$ 5.95M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 31.19M$ 29.68M$ 34.77M$ 82.79M$ 134.47M$ 76.24M
Net Income From Continuing And Discontinued Operation
$ -29.08M$ -28.45M$ -23.21M$ -44.21M$ -255.57M$ -73.70M
Normalized Income
$ -12.73M---$ -116.64M$ -73.70M
Interest Expense
----$ 4.39M-
EBIT
$ -30.32M$ -29.26M$ -33.93M$ -39.05M$ -251.44M$ -76.24M
EBITDA
$ -30.32M$ -29.26M$ -33.83M$ -39.05M$ -251.09M$ -75.54M
Currency in USD

VYNE Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis